These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18280125)

  • 21. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans.
    Anraku M; Arahira M; Mady FM; Khaled KA; Yamasaki K; Seo H; Imai T; Otagiri M
    Pharmazie; 2010 Jul; 65(7):461-6. PubMed ID: 20662311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissolution studies on tablets of ibuprofen using chitosan.
    Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
    Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules.
    Hannula AM; Marvola M; Rajamaeki M; Ojantakanen S
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():221-7. PubMed ID: 1820883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration.
    Kimura S; Imai T; Otagiri M
    Pharm Acta Helv; 1991; 66(4):120-4. PubMed ID: 1758897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
    González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
    Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
    Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
    Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["Non-solvent shock agglomeration technology" as a new alternative method for work on ibuprofen. 4. Production and evaluation of quick release forms].
    Möller T; Korsatko W
    Pharmazie; 2000 Jan; 55(1):53-8. PubMed ID: 10683872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of ibuprofen from beads for embolization: in vitro and in vivo studies.
    Borovac T; Pelage JP; Kasselouri A; Prognon P; Guiffant G; Laurent A
    J Control Release; 2006 Oct; 115(3):266-74. PubMed ID: 17045356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.
    Potthast H; Dressman JB; Junginger HE; Midha KK; Oeser H; Shah VP; Vogelpoel H; Barends DM
    J Pharm Sci; 2005 Oct; 94(10):2121-31. PubMed ID: 16136567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen.
    Godwin DA; Wiley CJ; Felton LA
    Eur J Pharm Biopharm; 2006 Jan; 62(1):85-93. PubMed ID: 16137872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orange juice enhances aluminium absorption from antacid preparation.
    Fairweather-Tait S; Hickson K; McGaw B; Reid M
    Eur J Clin Nutr; 1994 Jan; 48(1):71-3. PubMed ID: 8200332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems.
    Kokot Z; Zmidzińska H
    Acta Pol Pharm; 2001; 58(2):117-20. PubMed ID: 11501788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.
    Oladiran GS; Batchelor HK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):106-11. PubMed ID: 17321730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibuprofen ion-exchange fiber complex: improved dissolution and gastric tolerance based on ion exchange.
    Che X; Wang LH; Yang Y; Yuan Y; Wang QF; Wang Y; Li SM
    Drug Dev Ind Pharm; 2013 May; 39(5):744-51. PubMed ID: 22694127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
    Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
    Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen.
    Cilurzo F; Minghetti P; Casiraghi A; Tosi L; Pagani S; Montanari L
    Eur J Pharm Biopharm; 2005 May; 60(1):61-6. PubMed ID: 15848057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
    Möller T; Korsatko W
    Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.